# Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/impact-of-the-combined-timing-of-pd-1-pd-l1-inhibitors-and-chemotherapy-on-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Weitao Yao,Xu Zhao,Yixin Gong,Meiyue Zhang,Lichen Zhang,Qingqing Wu,Lin Wu,Zhimin Fan,Xiang Yan,Shuyue Jiao |
| Citations | 28 |
| DOI | 10.1016/j.esmoop.2021.100094 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.esmoopen.com/article/S205970292100051X/pdf |
| OpenAlex ID | https://openalex.org/W3144980886 |
| PMID | 33780892 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Zhimin Fan](https://scholariq.org/researchers/zhimin-fan/)

## Paper journal

- [ESMO Open](https://scholariq.org/journals/esmo-open/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.